Dysport® is an FDA-approved botulinum toxin formulation that temporarily reduces muscle activity to soften dynamic wrinkles — administered by Liz Lee RN at SynergyO3.
Dysport® is abobotulinumtoxinA — a purified protein that temporarily blocks acetylcholine release at the neuromuscular junction, preventing targeted muscles from contracting.
Dysport® binds to nerve terminals and prevents release of acetylcholine — the neurotransmitter that triggers muscle contraction — at the targeted injection site.
With contraction reduced, the overlying skin stops creasing with movement. Dynamic wrinkles — those caused by repeated facial expressions — soften or resolve.
Results emerge over 3–5 days as the neuromuscular block establishes. Full effect is typically visible by day 14, with results lasting 3–4 months for most patients.
As acetylcholine signaling gradually recovers, muscle activity returns to baseline. Dysport® is FDA-approved and has a well-established 20+ year safety profile in clinical use.
✓ Faster onset.
Dysport® typically shows effect within 2–3 days — faster than many alternatives, allowing for earlier assessment.
✓ Wider diffusion.
Dysport® spreads more evenly from the injection site, which can produce softer, more natural-looking results in large muscle groups like the forehead.
✓ Unit ratio transparency.
Dysport® is dosed differently than Botox (roughly 2.5:1 unit ratio). Liz Lee RN ensures full transparency in dosing so patients understand exactly what they receive.
✓ FDA-approved, RN-injected.
Dysport® is FDA-approved for glabellar lines. At SynergyO3, all injections are performed by Liz Lee RN — never delegated.
Liz Lee RN evaluates each patient’s anatomy individually. Common treatment areas include:
The vertical lines between the brows caused by corrugator and procerus muscle activity. The most common Dysport® indication — typically 50–60 units.
Horizontal lines across the forehead from frontalis muscle contraction. Dosed conservatively to preserve natural brow position and movement.
Lateral orbital lines from orbicularis oculi activity. Treatment softens the fan pattern at the outer corners of the eyes while preserving natural expression.
Combined treatment of frown lines, forehead, and crow’s feet — the most comprehensive approach to upper facial dynamic wrinkle reduction.
Targeted relaxation of depressor muscles allows the brow elevators to work unopposed, creating a subtle but meaningful lift to the lateral brow.
Injection into the masseter muscle reduces bulk and clenching force — addressing both jaw tension and lower face contouring in select patients.
Priced per unit — Liz Lee RN will discuss your estimated unit count during consultation based on your anatomy and goals.
Neurotoxin treatment works well alongside regenerative and resurfacing services. Common pairings at SynergyO3:
Neurotoxin addresses dynamic wrinkles from muscle movement while Genius RF microneedling targets skin texture, laxity, and collagen — a complementary approach covering both muscle and tissue layers.
Lutronic Ultra non-ablative laser addresses surface pigmentation and skin quality while Dysport® manages the dynamic component of aging — together covering both structural and movement-related concerns.
Combining neurotoxin for the upper face with RHA® lip filler provides comprehensive perioral rejuvenation — softening lines above the lip while adding natural volume and definition.
EBOO ozone therapy supports systemic inflammation reduction and cellular health. Some patients schedule EBOO alongside aesthetic treatments as part of a broader anti-aging and optimization protocol.
Schedule a Dysport® consultation with Liz Lee RN. She’ll assess your anatomy, walk through your goals, and build a treatment plan designed for your face — not a template.